Skip to content

pixlbio vs StemoniX

pixlbio logo

pixlbio

pixl x bio: from cells to pixels to predictions

21 employees · est. 2025 · Uppsala, Sweden

VS
StemoniX logo

StemoniX

Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research

1 employees · est. 2014 · Maple Grove, United States

StemoniX is the older company (2025 vs 2014); pixlbio is the larger of the two.

Side-by-Side Comparison

pixlbio StemoniX
Founded
2025 2014 older
Headquarters
Uppsala, Sweden Maple Grove, United States
Employees
21 larger 1
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care
Funding Stage
Series A Convertible Note
Total Funding
$11.53M $33.21M
Funding Rounds
6 11
Services
iPSC-derived Models, High-content Phenomic Analysis, Custom Studies and Analytics, Automated Experimentation, Predictive Modeling Not tracked yet
Target Customers
Biopharma Companies, Pharmaceutical Corporations, Research Institutions Not tracked yet
Taxonomy
IPSC-derived Human ModelsHigh-throughput ImagingAI-powered PhenomicsDrug DiscoverySafety TestingDisease Modeling +8 Stem Cell TechnologiesDrug DiscoveryPersonalized MedicineIPS CellsCardiomyocytesNeurons +8
Website
pixl.bio stemonix.com
pixlbio logo

About pixlbio

pixlbio, born from the merger of DefiniGEN and Phenaros, is pioneering the field of predictive biology by merging iPSC-derived human models with cutting-edge technologies such as high-throughput imaging and AI-powered phenomics. They are setting new standards in drug discovery and safety by capturin...

StemoniX logo

About StemoniX

StemoniX is a biotechnology startup based in the United States, founded in 2014, focusing on accelerating the discovery of new medicines through the development and scalable manufacture of human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and developme...

Also comparing in this category

Comparing more than these two?

Get pixlbio, StemoniX and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does pixlbio compare?

A PDF of pixlbio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

pixlbio was founded in 2025, based in Uppsala, Sweden, with 21 employees. pixlbio, born from the merger of DefiniGEN and Phenaros, is pioneering the field of predictive biology by merging iPSC-derived human models with cutting-edge technologies such as high-throughput imagi. StemoniX was founded in 2014, based in Maple Grove, United States, with 1 employees. StemoniX is a biotechnology startup based in the United States, founded in 2014, focusing on accelerating the discovery of new medicines through the development and scalable manufacture of human induc.
pixlbio has raised $11.53M and StemoniX $33.21M. Latest stage: pixlbio Series A, StemoniX Convertible Note.
Both work in Biotechnology and Health Care and list drug discovery, disease modeling and regenerative medicine among their focus areas.

Compare pixlbio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at pixlbio on 25 Mar 2026, and StemoniX on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout